Market Tracker

12/13 3:29pm ET

ImmunoCellular Therapeutics Ltd (NYSE American:IMUC)

0.2239
Delayed Data
As of 3:13pm ET
 -0.0037 / -1.63%
Today’s Change
0.17
Today|||52-Week Range
4.27
-89.08%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.23
Today’s open0.22
Day’s range0.21 - 0.24
Volume905,572
Average volume (3 months)2,392,492
Market cap$5.5M
Data as of 3:13pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)-31.50%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.13

Competitors

 Today’s
change
Today’s
% change
SGLBSigma Labs Inc-0.02-1.35%
YTENYield10 Bioscience I...+0.05+1.19%
BASIBioanalytical System...+0.02+0.72%
OPGNOpGen Inc-0.01-6.14%
Data as of 3:13pm ET, 12/13/2017

Financials

Next reporting dateMarch 9, 2018
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$0.00
Annual profit (last year)-$22.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Secretary
Gary S. Titus
President, Chief Executive Officer &
Director
Anthony J. Gringeri
Corporate headquarters
Calabasas, California

Forecasts